Quick facts
- A multipurpose solution cleans, rinses, disinfects and stores in one bottle; the disinfecting claim rests on the antimicrobial agents in it, not on the rinsing step.
- In the United States the product family is classified at 21 CFR 886.5928, Class II, product code LPN, and reaches market through a premarket notification.
- In Canada the same bottle is a medical device under the Medical Devices Regulations and needs a device licence before sale; there is no separate over-the-counter route for lens care.
- The technical evidence behind the disinfecting claim is written in ISO 14729 (microbiological requirements and test methods) and ISO 14730 (preservative efficacy), and both standards are cited by manufacturers on both sides of the border.
- A fitting practice that hands out diagnostic lenses carries the care system into its own infection-control record; the bottle a patient buys is a separate decision from the system the practice uses on its own trial set.
- Product entry text, standard titles and the classification database were read on 2026-10-18.
A multipurpose solution is the default bottle in most contact lens practices, which is exactly why it deserves a closer look than the shelf position it occupies. One liquid is asked to do four jobs, and the claim that it disinfects is a regulated claim with test methods behind it. This article sets out what the product is, how Canada and the United States each let it reach a patient, where the two routes differ, and what a fitting practice should keep on file — including the multipurpose solution stocked for trial lens care rather than bought at retail.
What does a multipurpose contact lens solution actually do?
Four functions are combined. A surfactant lifts deposit from the lens surface; a chelating or buffering component keeps the solution stable; the antimicrobial agent or agent pair does the disinfecting; and the same liquid is the storage medium, so the lens sits in it overnight. The cleaning step is mechanical as well as chemical: the lens is rubbed and rinsed before it goes into the case, and the solution in the case is replaced rather than replenished.
The disinfecting claim is the regulated part. A solution that only wets and rinses is a different product from one that claims disinfection, and the difference is not marketing language — it is the test package the manufacturer files. That package has to show the product reduces a defined inoculum of organisms within a stated contact time, and it has to show the preservative keeps working across the shelf life of the bottle, not only on the day it was filled.
Two practical points follow. First, the contact time printed on the label is part of the claim; a lens removed early has been cleaned and rinsed but not disinfected to the standard the label describes. Second, the case is part of the system. A solution that meets its microbiological requirements in a clean case can fail the same requirement in a case with biofilm on the base, which is why case replacement and drying face-down are part of the instruction rather than an afterthought.
How do Canada and the United States each license a multipurpose solution?
The routes are parallel, not shared. In the United States, a soft lens care product falls under 21 CFR 886.5928, the entry for accessories and soft lens products, at Class II with product code LPN. A manufacturer files a premarket notification, receives a clearance for a stated indication and labelling, and lists the device. The openFDA classification database returns the entry, class and product code, and those three values are what a buyer should see quoted in the supplier's paperwork rather than a general assurance that the product is registered.
In Canada, the same product is a device under the Medical Devices Regulations, SOR/98-282. Class II devices need a device licence before sale, and the manufacturer must hold the safety and effectiveness evidence behind the licence. The Regulations put non-corrective contact lenses in Class II, and lens care products sit in the same licensing stream: a bottle cannot be sold into Canada on the strength of a United States clearance alone.
That last sentence is the practical difference a purchasing office feels. A sales sheet that shows an FDA clearance number answers the American question. The Canadian question — is there a device licence for this product, held by this manufacturer, for this intended use — is answered by a different document, and the two are not interchangeable.
| Item | Canada | United States |
|---|---|---|
| Governing instrument | Medical Devices Regulations, SOR/98-282 | 21 CFR 886.5928 |
| Named entry | None specific to lens care; classified under the Regulations | Accessories, soft lens products |
| Class | Set by the Schedule 1 rule that applies to the stated use; lens care and non-corrective lenses sit in the Class II licensing stream | Class II |
| Product code | Not applicable | LPN |
| Pre-market route | Device licence for Class II and above | Premarket notification (510(k)) |
| Technical evidence | ISO 14729 and ISO 14730 test data | Same standards cited in the submission |
| Read on | Consolidated Regulations | Cornell LII text and openFDA, 2026-10-18 |
Do Canada and the United States test the disinfecting claim the same way?
ISO 14729 sets out two test methods for products that disinfect contact lenses by chemical means: a stand-alone procedure and a regimen procedure that tests the full care routine rather than the liquid alone. That distinction matters commercially, because a solution can pass as a liquid and still fail as a regimen when the rubbing and rinsing step is weakened in the instructions. ISO 14730 covers the preservative efficacy of the product, which is the part of the file that supports the in-use period after the bottle is opened.
The two standards answer different questions, and a purchasing decision that only asks about one of them is incomplete. ISO 14729 answers "does this regimen reduce the organisms it claims to reduce?" ISO 14730 answers "does the antimicrobial protection hold up while the bottle is open on a bathroom shelf?" A product with a strong stand-alone result and a weak preservative profile is a product that performs in the laboratory and deteriorates in use.
| Test question | Standard | What a buyer should ask for |
|---|---|---|
| Does the regimen reduce the challenge organisms? | ISO 14729 | Summary of stand-alone and regimen results, with contact time |
| Does the preservative hold across the in-use period? | ISO 14730 | In-use period stated on the label and supported in the file |
| Is the bottle sterile at fill? | Manufacturer sterility release | Release specification and lot record |
| Is the case part of the claim? | Labelling and instructions for use | Case replacement interval and drying instruction |
| Is the Canadian licence in place? | SOR/98-282 | Licence number and manufacturer name on the file |
How does a Canadian practice compare the same bottle with its US listing?
A Canadian practice that also supplies patients who travel, or that buys through a distributor serving both countries, ends up holding two documents for one product: a Canadian device licence and an American clearance. The two should agree on the essentials — intended use, contact time, in-use period, case instruction — and when they do not, the difference is usually a labelling version rather than a different liquid.
The version question is worth a line in the purchasing file. Labels are amended, indications are narrowed, and a distributor's spec sheet can lag a revision by a season. Reading the current instructions for use against the licence and the clearance takes minutes and prevents the more expensive problem: a practice teaching one contact time while the bottle in the drawer carries another.
What changes for a practice that uses solution on its own trial lenses?
Diagnostic and trial lenses are reused across patients in many practices, and the care system used on them is part of the infection-control procedure, not a retail choice. Two habits matter. The first is that the solution is replaced, not replenished — a case drained and filled without discarding the old liquid concentrates protein and dilutes the preservative. The second is that the case is treated as a consumable with a replacement date, because a case is the surface where biofilm forms first.
A written procedure should name the solution by product and manufacturer, state the disinfection contact time, state the case replacement interval, and record who is responsible for the weekly change of the trial-set solution. That procedure is what an inspector or an accreditation reviewer reads, and it is also what protects the practice when a patient reports irritation after a trial.
Which consumables does a fitting practice restock alongside the solution?
A fitting room runs on a short list: the solution itself, cases, and the absorbent and wiping items used at the slit lamp. Ordering them together keeps the procedure consistent, because a practice that changes solution brand without changing the written procedure creates a gap between what staff do and what the manual says.
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers. Reselling? become a distributor.
The three lines that move with a fitting room are the multipurpose solution for trial lens care, the eye patch and occlusion set used after procedures that leave the eye covered, and the Snellen and Amsler chart set that keeps acuity and macular checks on the same wall. The wider clinic supplies collection groups them for a single order.
What should the fitting record show?
The record that survives a review is short and specific: the care system the patient was fitted with, the disinfection contact time taught, the case replacement date, and the date the instruction was given. A record that says "MPS advised" answers none of the questions a reviewer asks, because it does not identify the product or the regimen.
For the practice's own trial set, the record is a log rather than a note: the date the solution was changed, the case replacement date, and the initials of the person who did it. A weekly line in a log is a small administrative habit with a large compliance return, because it turns an unwritten routine into evidence.
Sources
- 21 CFR 886.5928, accessories and soft lens products
- 21 CFR 886.5916, rigid gas permeable contact lens
- 21 CFR 886.5925, in-office tinting of contact lenses
- openFDA device classification API
- FDA product classification database
- Medical Devices Regulations, SOR/98-282
- Food and Drugs Act
- Health Canada, medical devices
- Health Canada, guidance documents on medical devices
- Canada Gazette, non-corrective contact lenses as Class II devices
- ISO 14729:2001, contact lens care products, microbiological requirements
- ISO 14729 stand-alone and regimen test methods, ANSI webstore record
- Canadian Association of Optometrists
- Public Health Ontario, infection prevention and control
- Public Health Ontario, reprocessing
- WHO, blindness and visual impairment fact sheet
- CLSI, general laboratory standards
- CCOHS, OSH answers
- Standards Council of Canada
- CSA Group
Printable lens care instruction sheet. A fitting room hands the same four instructions to every patient, and the sheet is the part that goes home. Print the contact lens care instruction sheet - it carries a line for the solution, the contact time, the case date and the practice stamp, on plain paper with no account and no sign-up.
Care interval generator. Set the fitting date and the case replacement interval and the page returns the review dates for the year, in the order a recall list is worked. Generate a lens care review calendar - one row per patient, printable at the desk.
Ask a compliance specialist. Whether a care product needs a Canadian device licence, and what the file must show, is a question with a document behind it. Ask a compliance specialist - written answer specific to your equipment and province, with the regulation or standard it is based on cited.
Related reading
- Hydrogen peroxide contact lens solutions in Canada vs the US: which rules apply
- Contact lens cases in Canada vs the US: which class applies
- Contact lens rewetting drops in Canada vs the US: which product rules apply
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. Health Canada MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.
Frequently Asked Questions
Is a multipurpose contact lens solution a Class II device in the United States?
Yes. It sits in the soft lens product family at 21 CFR 886.5928, Class II, product code LPN, and reaches market through a premarket notification rather than an exempt listing.
Does a Canadian clinic need a different document from the US clearance?
Yes. The Canadian route is a device licence under the Medical Devices Regulations, and a United States clearance does not replace it. A purchasing file should hold both when a product is sold in both countries.
Does the contact time on the label matter if the lens looks clean?
It does. The disinfecting claim is tied to the stated contact time, so a lens removed early has been cleaned and rinsed but not disinfected to the level the label describes.
Can a practice reuse solution in the case?
No. The case is drained and refilled with fresh solution, not replenished. Reusing the liquid concentrates deposit and dilutes the preservative that the in-use claim depends on.
How often should the lens case be replaced?
Follow the case manufacturer's stated interval and record the replacement date. Many cases carry a three-month instruction, and the date is the part a review asks for.
What should the practice record when it fits a patient with a new care system?
The product name and manufacturer, the disinfection contact time taught, the case replacement date, and the date the instruction was given. For the practice's own trial set, a weekly log line with the solution change and the initials of the person who did it.